Multiple endocrine neoplasia type 1 laboratory findings: Difference between revisions
Irfan Dotani (talk | contribs) No edit summary |
Irfan Dotani (talk | contribs) No edit summary |
||
Line 27: | Line 27: | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Endocrinology]] | |||
{{WS}} | {{WS}} | ||
{{WH}} | {{WH}} |
Revision as of 16:28, 21 July 2016
Multiple endocrine neoplasia type 1 Microchapters |
Differentiating Multiple endocrine neoplasia type 1 from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Multiple endocrine neoplasia type 1 laboratory findings On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 laboratory findings |
FDA on Multiple endocrine neoplasia type 1 laboratory findings |
CDC on Multiple endocrine neoplasia type 1 laboratory findings |
Multiple endocrine neoplasia type 1 laboratory findings in the news |
Blogs on Multiple endocrine neoplasia type 1 laboratory findings |
Directions to Hospitals Treating Multiple endocrine neoplasia type 1 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 1 laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [3]
Overview
Laboratory findings consistent with the diagnosis of multiple endocrine neoplasia type 1 include increased parathyroid hormone, increased gastrin concentration, and increased cortisol concentration.
Laboratory Findings
- Laboratory tests may be performed periodically to screen for multiple endocrine neoplasia type 1 tumors[1]